Price
Financials
Standalone, Rs crore| Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 220 | 233 | 274 | 259 | 293 | 176 | 47 | 12 | 6 | 2 | 2 | 1 |
| Expenses | 182 | 187 | 222 | 195 | 251 | 197 | 172 | 14 | 6 | 2 | 98 | 2 |
| Operating Profit | 38 | 46 | 53 | 63 | 42 | -21 | -126 | -2 | 1 | 0 | -95 | -0 |
| OPM % | 17% | 20% | 19% | 25% | 14% | -12% | -269% | -14% | 10% | 1.0% | -3,881% | -21% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -115 | -67 | 0 | 0 | 0 | 4 | -20 |
| Interest | 17 | 18 | 26 | 24 | 33 | 22 | -5 | -4 | 1 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 4 | 7 | 6 | 7 | 4 | 6 | 6 | 1 | 7 | 6 |
| Profit before tax | 18 | 25 | 23 | 33 | 2 | -165 | -191 | -4 | -6 | -2 | -99 | -26 |
| Tax % | 26% | 24% | 53% | 20% | 40% | -0% | -3% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 13 | 19 | 11 | 26 | 1 | -165 | -185 | -4 | -6 | -2 | -99 | -26 |
| EPS in Rs | 1.93 | 2.73 | 1.56 | 3.83 | 0.19 | -24.18 | -27.19 | -0.62 | -0.89 | -0.22 | -14.55 | -3.82 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Jun 2015 15m | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 144 | 157 | 176 | 218 | 298 | 363 | 437 | 664 | 911 | 787 | 12 |
| Expenses | 133 | 143 | 160 | 198 | 267 | 321 | 369 | 531 | 734 | 842 | 107 |
| Operating Profit | 11 | 14 | 16 | 20 | 31 | 41 | 68 | 134 | 177 | -55 | -95 |
| OPM % | 7% | 9% | 9% | 9% | 10% | 11% | 16% | 20% | 19% | -7% | -777% |
| Other Income | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | -170 | -16 |
| Interest | 5 | 7 | 7 | 11 | 14 | 16 | 28 | 59 | 77 | 71 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 13 | 14 | 29 | 20 |
| Profit before tax | 5 | 5 | 7 | 7 | 15 | 23 | 37 | 63 | 86 | -325 | -133 |
| Tax % | 39% | 20% | 26% | 33% | 31% | 26% | 48% | 35% | 32% | -2% | |
| Net Profit | 3 | 4 | 5 | 5 | 11 | 17 | 19 | 41 | 59 | -320 | -133 |
| EPS in Rs | 0.35 | 0.40 | 0.84 | 8.65 | -46.98 | -19.48 | |||||
| Dividend Payout % | 42% | 30% | 25% | 27% | 12% | 20% | 17% | 12% | 9% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 21% | 22% | -98% | ||
| Compounded Profit Growth | % | % | % | 32% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | 3% | 0% | -7% | -114% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Jun 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26 | 26 | 26 | 26 | 26 | 48 | 48 | 48 | 68 | 68 |
| Reserves | 12 | 15 | 19 | 22 | 69 | 73 | 95 | 146 | 211 | -110 |
| Borrowings | 57 | 85 | 86 | 104 | 123 | 184 | 362 | 520 | 623 | 750 |
| Other Liabilities | 22 | 31 | 42 | 40 | 50 | 65 | 98 | 128 | 189 | 77 |
| Total Liabilities | 117 | 158 | 173 | 192 | 268 | 370 | 603 | 842 | 1,092 | 784 |
| Fixed Assets | 26 | 29 | 30 | 35 | 36 | 45 | 242 | 251 | 349 | 275 |
| CWIP | 5 | 27 | 35 | 20 | 38 | 19 | 49 | 37 | 67 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 6 | 3 |
| Other Assets | 86 | 102 | 108 | 138 | 194 | 306 | 309 | 551 | 670 | 505 |
| Total Assets | 117 | 158 | 173 | 192 | 268 | 370 | 603 | 842 | 1,092 | 784 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Jun 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -9 | 10 | 16 | -13 | -8 | 12 | 7 | 13 | -60 | -151 |
| Cash from Investing Activity | -7 | -27 | -12 | 8 | -21 | -62 | -158 | -123 | -21 | 105 |
| Cash from Financing Activity | 7 | 20 | -8 | 5 | 42 | 55 | 152 | 112 | 63 | 44 |
| Net Cash Flow | -9 | 4 | -3 | -0 | 13 | 6 | 1 | 2 | -18 | -2 |
| Free Cash Flow | -16 | -16 | 4 | -5 | -29 | -50 | -149 | -108 | -79 | -39 |
| CFO/OP | -76% | 80% | 107% | -60% | -18% | 46% | 19% | 19% | -31% | 276% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Jun 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 135 | 152 | 143 | 140 | 131 | 135 | 142 | 133 | 133 | 221 |
| Inventory Days | 66 | 75 | 78 | 65 | 66 | 68 | 92 | 89 | 104 | 3 |
| Days Payable | 23 | 47 | 69 | 50 | 48 | 49 | 40 | 49 | 50 | 4 |
| Cash Conversion Cycle | 178 | 179 | 152 | 155 | 149 | 155 | 194 | 173 | 187 | 221 |
| Working Capital Days | 178 | 170 | 149 | 176 | 171 | 162 | 174 | 177 | 206 | 214 |
| ROCE % | 11% | 11% | 13% | 16% | 15% | 16% | 20% | 20% | -9% |
| Mar 2016 | Jun 2016 | |
|---|---|---|
| Promoters | 3.58% | 3.58% |
| DIIs | 0.02% | 0.02% |
| Public | 96.41% | 96.41% |
| No. of Shareholders | 71,277 | 71,277 |
Fundamentals
Market Cap₹ 31.7 Cr.
Current Price₹ 4.70
Book Value₹ -22.5
ROCE-8.56 %
ROE-114 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-98%
Compounded Profit Growth (TTM)32%
Standalone figures.
Valuation
P/E, 3-year average4.33x
P/B, 3-year average-0.06x
P/E, 5-year average5.24x
P/B, 5-year average0.30x
Profitability
Operating margin (excl. other income)-7.01%
Operating margin (incl. other income)-28.55%
EBITDA margin-337.22%
Pre-tax margin-1084.08%
Net profit margin-1084.00%
Net margin, latest quarter-1795.86%
ROE-269.86%
ROCE-31.59%
ROA-34.13%
ROE, 3-year average-73.64%
ROCE, 3-year average2.87%
ROA, 3-year average-7.47%
ROE, 5-year average-38.12%
ROCE, 5-year average7.92%
ROA, 5-year average-2.62%
ROIC (approx.)-8.63%
Tax rate1.61%
Other income / net worth401.11%
Growth
Sales growth (latest year)-13.61%
Profit growth (latest year)-643.36%
Sales CAGR, 3 years21.70%
Sales CAGR, 5 years21.46%
Sales growth QoQ-41.06%
Sales growth YoY (latest quarter)-88.06%
Per share
EPS (TTM)Rs -19.49
EPS (latest year)Rs -46.97
EPS (latest quarter)Rs -3.82
EPS, 3-year averageRs -9.97
EPS, 5-year averageRs -5.83
Book value per shareRs -6.21
Sales per shareRs 1.80
Cash flow per shareRs -22.19
Free cash flow per shareRs -5.72
Dividend per share, 3-year averageRs 0.90
Dividend per share, 5-year averageRs 0.48
Dividends
Dividend payout, 3-year average10.56%
Dividend payout, 5-year average14.63%
Efficiency
Asset turnover1.00x
Fixed asset turnover2.86x
Inventory turnover107.84x
Inventory days3 days
Debtor days221 days
Debtors turnover1.65x
Creditor days4 days
Cash conversion cycle221 days
Working capital days214 days
Leverage
Total debtRs 750 Cr
Cash and bankRs 3 Cr
Net debtRs 746 Cr
Debt to equity-17.73x
Interest coverage-0.87x
Owners' fund to total sources-5.39%
Debt to assets95.63%
Cash flow
Cash from Operating Activity (latest year)Rs -151 Cr
Cash from Investing Activity (latest year)Rs 105 Cr
Cash from Financing Activity (latest year)Rs 44 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -39 Cr
FCFE (approx.: FCF + change in debt)Rs 88 Cr
Cash from ops / profit, 5 years-0.24x
Statement figures
Net sales (TTM)Rs 12 Cr
Net sales (latest year)Rs 787 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -55 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -170 Cr
EBITDA (TTM)Rs -41 Cr
PBDT (TTM)Rs -112 Cr
Profit before tax (TTM)Rs -133 Cr
Tax (latest year)Rs -5 Cr
Net profit (TTM)Rs -133 Cr
Net profit (latest year)Rs -320 Cr
Net profit (latest quarter)Rs -26 Cr
Depreciation (TTM)Rs 20 Cr
Depreciation (latest quarter)Rs 6 Cr
Interest (TTM)Rs 71 Cr
Cost of goods sold (latest year)Rs 794 Cr
Total expenditure (latest year)Rs 842 Cr
Total income (latest year)Rs 617 Cr
Share capitalRs 68 Cr
ReservesRs -110 Cr
Shareholders' fundsRs -42 Cr
Total assetsRs 784 Cr
Net blockRs 275 Cr
InvestmentsRs 3 Cr
ReceivablesRs 478 Cr
InventoryRs 7 Cr
Other liabilitiesRs 77 Cr
Shares outstanding (crore)6.81
Ownership
Promoter holding3.58%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 3 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Receivables outrunning sales Receivables grew 43% vs sales -14% in 2015 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2016Sales ₹1 Cr -91.7% vs Jun 2015.
Net loss ₹26 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Arvind Remedies Ltd?
Arvind Remedies Ltd (531823) has a market capitalisation of Rs 31.7 Cr. at the close.
What were Arvind Remedies Ltd's latest quarterly results?
In the Jun 2016 quarter, Arvind Remedies Ltd sales was Rs 1 Cr (-91.7% vs Jun 2015) with a net loss of Rs 26 Cr.